Cystic Fibrosis Pipeline Therapeutics Market Growth and Insights 2017 – Key Companies Pipeline Products Development Analysis provides comprehensive information on the therapeutics under development for Cystic Fibrosis (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the Cystic Fibrosis therapeutics its complete research and development history and latest news and press releases. Cystic Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cystic Fibrosis and features dormant and discontinued projects. Cystic Fibrosis (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Get Discount on report at http://www.reportsnreports.com/contacts/discount.aspx?name=992880. (This report is available at 15% Discount for Single User License and 20% Discount for Corporate Users License till 01 September 2017).
Companies profiled in report are Achaogen Inc, Actelion Ltd, Advanced Inhalation Therapies (AIT) Ltd, Aeolus Pharmaceuticals Inc, Alaxia SAS, AlgiPharma AS, AmpliPhi Biosciences Corp, Apteeus, Arch Biopartners Inc, Arcturus Therapeutics Inc, Aridis Pharmaceuticals LLC, AstraZeneca Plc, Bayer AG, Boehringer Ingelheim GmbH, Catabasis Pharmaceuticals Inc, Celtaxsys Inc, Chiesi Farmaceutici SpA, Cilian AG, Concert Pharmaceuticals Inc, CRISPR Therapeutics, Cyclacel Pharmaceuticals Inc, DiscoveryBiomed Inc, Editas Medicine Inc, Eloxx Pharmaceuticals Ltd, Enterprise Therapeutics Ltd, Errant Gene Therapeutics LLC, ethris GmbH, Galapagos NV, Gilead Sciences Inc, GlaxoSmithKline Plc, Grifols SA, Grupo Praxis Pharmaceutical SA, Horizon Pharma Plc, ID Pharma Co Ltd, Immun System IMS AB, Insmed Inc, Invion Ltd, Ionis Pharmaceuticals Inc, JHL Biotech Inc, Kamada Ltd, Kyorin Pharmaceutical Co Ltd, La Jolla Pharmaceutical Company, Lakewood-Amedex Inc, Lamellar Biomedical Ltd, Laurent Pharmaceuticals Inc, Lexicon Pharmaceuticals Inc, Mast Therapeutics Inc, Merck & Co Inc, Microbion Corp, Mucokinetica Ltd, Novabiotics Ltd, Novartis AG, OSE Immunotherapeutics, Paranta Biosciences Ltd, Parion Sciences Inc, Pfizer Inc, Pharmaxis Ltd, PhaseBio Pharmaceuticals Inc, Polyphor Ltd, Progenra Inc, ProMetic Life Sciences Inc, ProQR Therapeutics NV, Protalix BioTherapeutics Inc, Proteostasis Therapeutics Inc, Pulmatrix Inc, RaNA Therapeutics Inc, ReveraGen BioPharma Inc, Savara Inc, Shionogi & Co Ltd, SOM Biotech SL, Synedgen Inc, Synovo GmbH, Vanda Pharmaceuticals Inc, Verona Pharma Plc, Vertex Pharmaceuticals Inc, Xenetic Biosciences Inc.
Cystic Fibrosis pipeline guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 1, 5, 25, 27, 1, 55, 25 and 2 respectively. Similarly, the Universities portfolio in Phase II, Preclinical, Discovery and Unknown stages comprises 2, 4, 7 and 1 molecule, respectively for Cystic Fibrosis.
Order single user licensed copy of report at http://www.reportsnreports.com/purchase.aspx?name=992880 .
The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The pipeline guide provides a snapshot of the global therapeutic landscape of Cystic Fibrosis (Respiratory) and reviews pipeline therapeutics for Cystic Fibrosis (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources. Report covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages and features descriptive drug profiles for the pipeline products which comprise product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.The pipeline guide reviews key companies involved in Cystic Fibrosis (Respiratory) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Cystic Fibrosis (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Report encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Cystic Fibrosis (Respiratory).
ReportsnReports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
Tel: + 1 888 391 5441